Geneos Wealth Management’s Procter & Gamble PG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.56M | Sell |
24,265
-4,870
| -17% | -$709K | 0.07% | 275 |
|
|
2026
Q1 | $4.21M | Sell |
29,135
-10,015
| -26% | -$1.52M | 0.1% | 230 |
|
|
2025
Q4 | $5.61M | Buy |
39,150
+14,170
| +57% | +$2.09M | 0.14% | 188 |
|
|
2025
Q3 | $3.84M | Sell |
24,980
-3,667
| -13% | -$573K | 0.1% | 247 |
|
|
2025
Q2 | $4.56M | Buy |
28,647
+9,286
| +48% | +$1.52M | 0.11% | 228 |
|
|
2025
Q1 | $3.3M | Buy |
19,361
+2,040
| +12% | +$342K | 0.11% | 224 |
|
|
2024
Q4 | $2.9M | Buy |
+17,321
| New | +$2.95M | 0.1% | 220 |
|
|
2022
Q1 | – | Sell |
-59,726
| Closed | -$9.77M | – | 2923 |
|
|
2021
Q4 | $9.77M | Sell |
59,726
-1,952
| -3% | -$290K | 0.37% | 53 |
|
|
2021
Q3 | $8.61M | Sell |
61,678
-4,204
| -6% | -$596K | 0.33% | 59 |
|
|
2021
Q2 | $8.95M | Sell |
65,882
-59,329
| -47% | -$8.03M | 0.35% | 58 |
|
|
2021
Q1 | $16.7M | Sell |
125,211
-4,996
| -4% | -$652K | 0.47% | 46 |
|
|
2020
Q4 | $9.79M | Buy |
130,207
+58,703
| +82% | +$8.2M | 0.39% | 52 |
|
|
2020
Q3 | $9.84M | Sell |
71,504
-4,010
| -5% | -$532K | 0.51% | 39 |
|
|
2020
Q2 | $8.7M | Sell |
75,514
-1,296
| -2% | -$151K | 0.48% | 39 |
|
|
2020
Q1 | $8.46M | Buy |
76,810
+1,161
| +2% | +$139K | 0.57% | 31 |
|
|
2019
Q4 | $9.54M | Buy |
75,649
+1,385
| +2% | +$169K | 0.51% | 37 |
|
|
2019
Q3 | $9.25M | Sell |
74,264
-4,901
| -6% | -$579K | 0.55% | 34 |
|
|
2019
Q2 | $8.68M | Sell |
79,165
-2,943
| -4% | -$314K | 0.54% | 35 |
|
|
2019
Q1 | $8.54M | Sell |
82,108
-213
| -0.3% | -$20.7K | 0.56% | 33 |
|
|
2018
Q4 | $7.51M | Sell |
82,321
-2,614
| -3% | -$234K | 0.56% | 35 |
|
|
2018
Q3 | $7.07M | Buy |
84,935
+1,794
| +2% | +$147K | 0.47% | 41 |
|
|
2018
Q2 | $6.49M | Sell |
83,141
-8,097
| -9% | -$609K | 0.51% | 45 |
|
|
2018
Q1 | $7.23M | Sell |
91,238
-6,504
| -7% | -$542K | 0.63% | 35 |
|
|
2017
Q4 | $8.98M | Buy |
97,742
+6,810
| +7% | +$612K | 0.8% | 21 |
|
|
2017
Q3 | $8.27M | Buy |
90,932
+6,727
| +8% | +$612K | 0.82% | 18 |
|
|
2017
Q2 | $7.34M | Sell |
84,205
-4,586
| -5% | -$404K | 0.75% | 26 |
|
|
2017
Q1 | $7.98M | Buy |
88,791
+7,324
| +9% | +$649K | 0.83% | 18 |
|
|
2016
Q4 | $6.85M | Buy |
81,467
+2,403
| +3% | +$205K | 0.9% | 17 |
|
|
2016
Q3 | $7.1M | Sell |
79,064
-1,687
| -2% | -$147K | 0.96% | 17 |
|
|
2016
Q2 | $6.85M | Sell |
80,751
-5,157
| -6% | -$423K | 0.99% | 15 |
|
|
2016
Q1 | $7.17M | Buy |
+85,908
| New | +$6.92M | 1.1% | 13 |
|
Other funds holding PG
Geneos Wealth Management's PG Position: Q2 2026 in Review
Geneos Wealth Management reduced its Procter & Gamble (PG) stake by 17% in Q2 2026, selling an estimated $709K and leaving 24,265 shares worth $3.56M. The position accounts for 0.07% of the portfolio, ranked #275.
Geneos Wealth Management first reported a position in PG in Q1 2016 and has held it in 31 quarters since. The position peaked at $16.7M in Q1 2021. 4,021 funds tracked by Wall St. Rank hold PG as of Q2 2026.
- Geneos Wealth Management held 24,265 shares of Procter & Gamble worth $3.56M as of Q2 2026.
- Geneos Wealth Management sold 4,870 Procter & Gamble shares in Q2 2026, an estimated $709K.
- Procter & Gamble made up 0.07% of Geneos Wealth Management's portfolio in Q2 2026, its #275 holding.
- Geneos Wealth Management first reported a position in Procter & Gamble in Q1 2016 and has held it in 31 quarters since.
- Geneos Wealth Management's Procter & Gamble position peaked at $16.7M in Q1 2021.
- 4,021 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.